Angiosarcoma: A tissue microarray study with diagnostic implications

American Journal of Dermatopathology

Volumn 35, Issue 4, 2013, Pages 432-437

  Rao, Priya ^a   Lahat, Guy ^b   Arnold, Christina ^a   Gavino, Alde Carlo ^c   Lahat, Sharon ^b   Hornick, Jason L ^d   Lev, Dina ^b   Lazar, Alexander J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

angiosarcoma; ERG; FLI 1; immunohistochemistry; survival; tissue microarray

Indexed keywords

ADULT; ANGIOSARCOMA; ARTICLE; BONE METASTASIS; BONE TUMOR; BRAIN METASTASIS; BREAST TUMOR; FEMALE; HEART TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAROTID METASTASIS; PRIORITY JOURNAL; SKIN TUMOR; SOFT TISSUE TUMOR; TISSUE MICROARRAY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR RECURRENCE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD31; ANTIGENS, CD34; BIOPSY; DISEASE-FREE SURVIVAL; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FACTOR VIII; FEMALE; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATINS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; SOFT TISSUE NEOPLASMS; TIME FACTORS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84878952601     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318271295a     Document Type: Article

References (36)

1. Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer. 1981;48:1907-1921. (Pubitemid 11022897)
2. Alles JU, Bosslet K. Immunocytochemistry of angiosarcomas. A study of 19 cases with special emphasis on the applicability of endothelial cell specific markers to routinely prepared tissues. Am J Clin Pathol. 1988; 89:463-471.
3. Kuzu I, Bicknell R, Harris AL, et al. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol. 1992;45:143-148.
4. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440. (Pubitemid 34326952)
5. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394. (Pubitemid 29094089)
6. Abraham JA, Hornicek FJ, Kaufman AM, et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14:1953-1967. (Pubitemid 46870934)
7. Fayette J, Martin E, Piperno-Neumann S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18:2030-2036. (Pubitemid 350286245)
8. Mark RJ, Poen JC, Tran LM, et al. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 1996;77:2400-2406.
9. Ohsawa M, Naka N, Tomita Y, et al. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer. 1995;75:2867-2874.
10. Poblet E, Gonzalez-Palacios F, Jimenez FJ. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch. 1996;428:217-221. (Pubitemid 26265741)
11. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005;46:396-402. (Pubitemid 40516755)
12. Chaux A, Albadine R, Toubaji A, et al. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol. 2011;35:1014-1020.
13. Birdsey GM, Dryden NH, Amsellem V, et al. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood. 2008;111:3498-3506.
14. Baltzinger M, Mager-Heckel AM, Remy P. Xl erg: expression pattern and overexpression during development plead for a role in endothelial cell differentiation. Dev Dyn. 1999;216:420-433.
15. Miettinen M, Wang ZF, Paetau A, et al. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol. 35:432-441.
16. McKay KM, Doyle LA, Lazar AJ, et al. Expression of ERG, an Ets family transcription factor, distinguishes cutaneous angiosarcoma from histological mimics. Histopathology. 2012. PMID: 22716285. Epub ahead of print.
17. Folpe AL, Hill CE, Parham DM, et al. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol. 2000;24:1657-1662.
18. Folpe AL, Chand EM, Goldblum JR, et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25:1061-1066. (Pubitemid 32685904)
19. Mukai K, Rosai J, Burgdorf WH. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol. 1980;4:273-276. (Pubitemid 10114247)
20. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22:683-697. (Pubitemid 28280270)
21. Orchard GE, Zelger B, Jones EW, et al. An immunocytochemical assessment of 19 cases of cutaneous angiosarcoma. Histopathology. 1996;28:235-240. (Pubitemid 26091914)
22. McKenney JK, Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol. 2001;25: 1167-1173. (Pubitemid 32777716)
23. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7:82-90.
24. De Young BR, Frierson HF Jr, Ly MN, et al. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol. 1998;110:374-377. (Pubitemid 28406996)
25. Nicholson SA, McDermott MB, DeYoung BR, et al. CD31 immunoreactivity in small round cell tumors. Appl Immunohistochem Mol Morphol. 2000;8:19-24. (Pubitemid 30152349)
26. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999; 30:934-942. (Pubitemid 29380517)
27. Ramani P, Bradley NJ, Fletcher CD. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology. 1990;17:237-242. (Pubitemid 20275966)
28. Fletcher CD, Ramani P. QBEnd/10: a useful, but by no means specific, marker of Kaposi's sarcoma. J Pathol. 1990;162:273-274.
29. Russell Jones R, Orchard G, Zelger B, et al. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol. 1995;48:1011-1016.
30. Suster S, Wong TY. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol. 1994;16:355-363. (Pubitemid 24284340)
31. Holden CA, Spaull J, Das AK, et al. The histogenesis of angiosarcoma of the face and scalp: an immunohistochemical and ultrastructural study. Histopathology. 1987;11:37-51. (Pubitemid 17024334)
32. Folpe AL, Veikkola T, Valtola R, et al. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol. 2000;13:180-185. (Pubitemid 30109106)
33. Hansen T, Katenkamp K, Bittinger F, et al. D2-40 labeling in lymphangiomyoma/ lymphangiomyomatosis of the soft tissue: further evidence of lymphangiogenic tumor histogenesis. Virchows Arch. 2007;450:449-453. (Pubitemid 46466390)
34. Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol. 2005;8: 181-189. (Pubitemid 40895696)
35. Fletcher CD, Beham A, Bekir S, et al. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol. 1991;15:915-924.
36. Gray MH, Rosenberg AE, Dickersin GR, et al. Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol. 1990;21:212-217. (Pubitemid 20087165)